APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Oral Proteins and Peptides

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Oral Proteins and Peptides Industry Growth and Trends Forecast to 2032

21 December 202590 pages

Choose your research edition.

Industry ResearchOral Proteins and Peptides Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Proteins and Peptides Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Oral Proteins and Peptides Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Proteins and Peptides Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Proteins and Peptides Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Oral Proteins and Peptides market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Oral Proteins and Peptides is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Oral Proteins and Peptides is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Proteins and Peptides is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral Proteins and Peptides include Ironwood & Allergan, Novo Nordisk, Synergy Pharmaceuticals （Salix）, Novartis and Chiasma (Amryt Pharma), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Oral Proteins and Peptides market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Oral Proteins and Peptides market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oral Proteins and Peptides market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oral Proteins and Peptides.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Oral Proteins and Peptides market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Oral Proteins and Peptides Market by Company

Ironwood & Allergan

Novo Nordisk

Synergy Pharmaceuticals （Salix）

Novartis

Chiasma (Amryt Pharma)

Oral Proteins and Peptides Segment by Type

Linaclotide

Insulin

Plecanatide

Cyclosporine

Octreotide

Oral Proteins and Peptides Segment by Application

Gastric & Digestive Disorders

Bone Diseases

Diabetes

Hormonal Disorders

Oral Proteins and Peptides Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Proteins and Peptides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Proteins and Peptides and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Proteins and Peptides.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oral Proteins and Peptides manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Oral Proteins and Peptides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Linaclotide Table 2. Major Company of Insulin Table 3. Major Company of Plecanatide Table 4. Major Company of Cyclosporine Table 5. Major Company of Octreotide Table 6. Global Oral Proteins and Peptides Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Oral Proteins and Peptides Sales by Type (2021-2026) & (Kg) Table 8. Global Oral Proteins and Peptides Sales Market Share in Volume by Type (2021-2026) Table 9. Global Oral Proteins and Peptides Sales by Type (2021-2026) & (US$ Million) Table 10. Global Oral Proteins and Peptides Sales Market Share in Value by Type (2021-2026) Table 11. Global Oral Proteins and Peptides Price by Type (2021-2026) & (US$/mg) Table 12. Global Oral Proteins and Peptides Sales by Type (2027-2032) & (Kg) Table 13. Global Oral Proteins and Peptides Sales Market Share in Volume by Type (2027-2032) Table 14. Global Oral Proteins and Peptides Sales by Type (2027-2032) & (US$ Million) Table 15. Global Oral Proteins and Peptides Sales Market Share in Value by Type (2027-2032) Table 16. Global Oral Proteins and Peptides Price by Type (2027-2032) & (US$/mg) Table 17. North America Oral Proteins and Peptides Sales by Type (2021-2026) & (Kg) Table 18. North America Oral Proteins and Peptides Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Oral Proteins and Peptides Sales by Type (2021-2026) & (Kg) Table 20. Europe Oral Proteins and Peptides Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Oral Proteins and Peptides Sales by Type (2021-2026) & (Kg) Table 22. Asia-Pacific Oral Proteins and Peptides Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Oral Proteins and Peptides Sales by Type (2021-2026) & (Kg) Table 24. Latin America Oral Proteins and Peptides Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Oral Proteins and Peptides Sales by Type (2021-2026) & (Kg) Table 26. Middle East and Africa Oral Proteins and Peptides Sales by Type (2021-2026) & (US$ Million) Table 27. Oral Proteins and Peptides Industry Trends Table 28. Oral Proteins and Peptides Industry Drivers Table 29. Oral Proteins and Peptides Industry Opportunities and Challenges Table 30. Oral Proteins and Peptides Industry Restraints Table 31. Global Oral Proteins and Peptides Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Oral Proteins and Peptides Revenue Market Share by Company (2021-2026) Table 33. Global Oral Proteins and Peptides Sales by Company (2021-2026) & (Kg) Table 34. Global Oral Proteins and Peptides Sales Share by Company (2021-2026) Table 35. Global Oral Proteins and Peptides Market Price by Company (2021-2026) & (US$/mg) Table 36. Global Oral Proteins and Peptides Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Oral Proteins and Peptides Major Company Production Sites and Headquarters Table 38. Global Oral Proteins and Peptides Company, Product Type & Application Table 39. Global Oral Proteins and Peptides Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Oral Proteins and Peptides by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Oral Proteins and Peptides Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Oral Proteins and Peptides Sales by Region (2021-2026) & (Kg) Table 44. Global Oral Proteins and Peptides Sales Market Share in Volume by Region (2021-2026) Table 45. Global Oral Proteins and Peptides Sales by Region (2021-2026) & (US$ Million) Table 46. Global Oral Proteins and Peptides Sales Market Share in Value by Region (2021-2026) Table 47. Global Oral Proteins and Peptides Sales (Kg), Value (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 48. Global Oral Proteins and Peptides Sales by Region (2027-2032) & (Kg) Table 49. Global Oral Proteins and Peptides Sales Market Share in Volume by Region (2027-2032) Table 50. Global Oral Proteins and Peptides Sales by Region (2027-2032) & (US$ Million) Table 51. Global Oral Proteins and Peptides Sales Market Share in Value by Region (2027-2032) Table 52. Global Oral Proteins and Peptides Sales (Kg), Value (US$ Million), Price (US$/mg) and Gross Margin (2027-2032) Table 53. Global Oral Proteins and Peptides Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Oral Proteins and Peptides Sales by Application (2021-2026) & (Kg) Table 55. Global Oral Proteins and Peptides Sales Market Share in Volume by Application (2021-2026) Table 56. Global Oral Proteins and Peptides Sales by Application (2021-2026) & (US$ Million) Table 57. Global Oral Proteins and Peptides Sales Market Share in Value by Application (2021-2026) Table 58. Global Oral Proteins and Peptides Price by Application (2021-2026) & (US$/mg) Table 59. Global Oral Proteins and Peptides Sales by Application (2027-2032) & (Kg) Table 60. Global Oral Proteins and Peptides Sales Market Share in Volume by Application (2027-2032) Table 61. Global Oral Proteins and Peptides Sales by Application (2027-2032) & (US$ Million) Table 62. Global Oral Proteins and Peptides Sales Market Share in Value by Application (2027-2032) Table 63. Global Oral Proteins and Peptides Price by Application (2027-2032) & (US$/mg) Table 64. North America Oral Proteins and Peptides Sales by Application (2021-2026) & (Kg) Table 65. North America Oral Proteins and Peptides Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Oral Proteins and Peptides Sales by Application (2021-2026) & (Kg) Table 67. Europe Oral Proteins and Peptides Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Oral Proteins and Peptides Sales by Application (2021-2026) & (Kg) Table 69. Asia-Pacific Oral Proteins and Peptides Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Oral Proteins and Peptides Sales by Application (2021-2026) & (Kg) Table 71. Latin America Oral Proteins and Peptides Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Oral Proteins and Peptides Sales by Application (2021-2026) & (Kg) Table 73. Middle East and Africa Oral Proteins and Peptides Sales by Application (2021-2026) & (US$ Million) Table 74. Ironwood & Allergan Company Information Table 75. Ironwood & Allergan Business Overview Table 76. Ironwood & Allergan Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 77. Ironwood & Allergan Oral Proteins and Peptides Product Portfolio Table 78. Ironwood & Allergan Recent Development Table 79. Novo Nordisk Company Information Table 80. Novo Nordisk Business Overview Table 81. Novo Nordisk Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 82. Novo Nordisk Oral Proteins and Peptides Product Portfolio Table 83. Novo Nordisk Recent Development Table 84. Synergy Pharmaceuticals （Salix） Company Information Table 85. Synergy Pharmaceuticals （Salix） Business Overview Table 86. Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 87. Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Product Portfolio Table 88. Synergy Pharmaceuticals （Salix） Recent Development Table 89. Novartis Company Information Table 90. Novartis Business Overview Table 91. Novartis Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 92. Novartis Oral Proteins and Peptides Product Portfolio Table 93. Novartis Recent Development Table 94. Chiasma (Amryt Pharma) Company Information Table 95. Chiasma (Amryt Pharma) Business Overview Table 96. Chiasma (Amryt Pharma) Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 97. Chiasma (Amryt Pharma) Oral Proteins and Peptides Product Portfolio Table 98. Chiasma (Amryt Pharma) Recent Development Table 99. North America Oral Proteins and Peptides Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 100. North America Oral Proteins and Peptides Sales by Country (2021-2026) & (Kg) Table 101. North America Oral Proteins and Peptides Sales Market Share by Country (2021-2026) Table 102. North America Oral Proteins and Peptides Sales Forecast by Country (2027-2032) & (Kg) Table 103. North America Oral Proteins and Peptides Sales Market Share Forecast by Country (2027-2032) Table 104. North America Oral Proteins and Peptides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 105. North America Oral Proteins and Peptides Market Size by Country (2021-2026) & (US$ Million) Table 106. North America Oral Proteins and Peptides Market Share by Country (2021-2026) Table 107. North America Oral Proteins and Peptides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 108. North America Oral Proteins and Peptides Market Share Forecast by Country (2027-2032) Table 109. Europe Oral Proteins and Peptides Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 110. Europe Oral Proteins and Peptides Sales by Country (2021-2026) & (Kg) Table 111. Europe Oral Proteins and Peptides Sales Market Share by Country (2021-2026) Table 112. Europe Oral Proteins and Peptides Sales Forecast by Country (2027-2032) & (Kg) Table 113. Europe Oral Proteins and Peptides Sales Market Share Forecast by Country (2027-2032) Table 114. Europe Oral Proteins and Peptides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 115. Europe Oral Proteins and Peptides Market Size by Country (2021-2026) & (US$ Million) Table 116. Europe Oral Proteins and Peptides Market Share by Country (2021-2026) Table 117. Europe Oral Proteins and Peptides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 118. Europe Oral Proteins and Peptides Market Share Forecast by Country (2027-2032) Table 119. Asia-Pacific Oral Proteins and Peptides Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 120. Asia-Pacific Oral Proteins and Peptides Sales by Country (2021-2026) & (Kg) Table 121. Asia-Pacific Oral Proteins and Peptides Sales Market Share by Country (2021-2026) Table 122. Asia-Pacific Oral Proteins and Peptides Sales Forecast by Country (2027-2032) & (Kg) Table 123. Asia-Pacific Oral Proteins and Peptides Sales Market Share Forecast by Country (2027-2032) Table 124. Asia-Pacific Oral Proteins and Peptides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. Asia-Pacific Oral Proteins and Peptides Market Size by Country (2021-2026) & (US$ Million) Table 126. Asia-Pacific Oral Proteins and Peptides Market Share by Country (2021-2026) Table 127. Asia-Pacific Oral Proteins and Peptides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. Asia-Pacific Oral Proteins and Peptides Market Share Forecast by Country (2027-2032) Table 129. Latin America Oral Proteins and Peptides Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 130. Latin America Oral Proteins and Peptides Sales by Country (2021-2026) & (Kg) Table 131. Latin America Oral Proteins and Peptides Sales Market Share by Country (2021-2026) Table 132. Latin America Oral Proteins and Peptides Sales Forecast by Country (2027-2032) & (Kg) Table 133. Latin America Oral Proteins and Peptides Sales Market Share Forecast by Country (2027-2032) Table 134. Latin America Oral Proteins and Peptides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Latin America Oral Proteins and Peptides Market Size by Country (2021-2026) & (US$ Million) Table 136. Latin America Oral Proteins and Peptides Market Share by Country (2021-2026) Table 137. Latin America Oral Proteins and Peptides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Latin America Oral Proteins and Peptides Market Share Forecast by Country (2027-2032) Table 139. Middle East and Africa Oral Proteins and Peptides Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 140. Middle East and Africa Oral Proteins and Peptides Sales by Country (2021-2026) & (Kg) Table 141. Middle East and Africa Oral Proteins and Peptides Sales Market Share by Country (2021-2026) Table 142. Middle East and Africa Oral Proteins and Peptides Sales Forecast by Country (2027-2032) & (Kg) Table 143. Middle East and Africa Oral Proteins and Peptides Sales Market Share Forecast by Country (2027-2032) Table 144. Middle East and Africa Oral Proteins and Peptides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Middle East and Africa Oral Proteins and Peptides Market Size by Country (2021-2026) & (US$ Million) Table 146. Middle East and Africa Oral Proteins and Peptides Market Share by Country (2021-2026) Table 147. Middle East and Africa Oral Proteins and Peptides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Middle East and Africa Oral Proteins and Peptides Market Share Forecast by Country (2027-2032) Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. Oral Proteins and Peptides Distributors List Table 152. Oral Proteins and Peptides Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Oral Proteins and Peptides Image Figure 2. Global Oral Proteins and Peptides Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Proteins and Peptides Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral Proteins and Peptides Sales (2021-2032) & (Kg) Figure 5. Linaclotide Image Figure 6. Global Linaclotide Sales YoY Growth (2021-2032) & (Kg) Figure 7. Insulin Image Figure 8. Global Insulin Sales YoY Growth (2021-2032) & (Kg) Figure 9. Plecanatide Image Figure 10. Global Plecanatide Sales YoY Growth (2021-2032) & (Kg) Figure 11. Cyclosporine Image Figure 12. Global Cyclosporine Sales YoY Growth (2021-2032) & (Kg) Figure 13. Octreotide Image Figure 14. Global Octreotide Sales YoY Growth (2021-2032) & (Kg) Figure 15. Global Oral Proteins and Peptides Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Oral Proteins and Peptides Market Share by Type 2025 VS 2032 Figure 17. North America Oral Proteins and Peptides Sales Market Share in Volume by Type in 2025 Figure 18. North America Oral Proteins and Peptides Sales Market Share in Value by Type in 2025 Figure 19. Europe Oral Proteins and Peptides Sales Market Share in Volume by Type in 2025 Figure 20. Europe Oral Proteins and Peptides Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Oral Proteins and Peptides Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Oral Proteins and Peptides Sales Market Share in Value by Type in 2025 Figure 23. Latin America Oral Proteins and Peptides Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Oral Proteins and Peptides Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Oral Proteins and Peptides Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Oral Proteins and Peptides Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Oral Proteins and Peptides Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Gastric & Digestive Disorders Image Figure 30. Global Gastric & Digestive Disorders Sales YoY Growth (2021-2032) & (Kg) Figure 31. Bone Diseases Image Figure 32. Global Bone Diseases Sales YoY Growth (2021-2032) & (Kg) Figure 33. Diabetes Image Figure 34. Global Diabetes Sales YoY Growth (2021-2032) & (Kg) Figure 35. Hormonal Disorders Image Figure 36. Global Hormonal Disorders Sales YoY Growth (2021-2032) & (Kg) Figure 37. Global Oral Proteins and Peptides Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Oral Proteins and Peptides Market Share by Application 2025 VS 2032 Figure 39. North America Oral Proteins and Peptides Sales Market Share in Volume by Application in 2025 Figure 40. North America Oral Proteins and Peptides Sales Market Share in Value by Application in 2025 Figure 41. Europe Oral Proteins and Peptides Sales Market Share in Volume by Application in 2025 Figure 42. Europe Oral Proteins and Peptides Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Oral Proteins and Peptides Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Oral Proteins and Peptides Sales Market Share in Value by Application in 2025 Figure 45. Latin America Oral Proteins and Peptides Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Oral Proteins and Peptides Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Oral Proteins and Peptides Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Oral Proteins and Peptides Sales Market Share in Value by Application in 2025 Figure 49. North America Oral Proteins and Peptides Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 50. North America Oral Proteins and Peptides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Oral Proteins and Peptides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Oral Proteins and Peptides Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Oral Proteins and Peptides Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 54. Europe Oral Proteins and Peptides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Oral Proteins and Peptides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Oral Proteins and Peptides Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Oral Proteins and Peptides Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 58. Asia-Pacific Oral Proteins and Peptides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Oral Proteins and Peptides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Oral Proteins and Peptides Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Oral Proteins and Peptides Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 62. Latin America Oral Proteins and Peptides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Oral Proteins and Peptides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Oral Proteins and Peptides Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Oral Proteins and Peptides Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 66. Middle East and Africa Oral Proteins and Peptides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Oral Proteins and Peptides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Oral Proteins and Peptides Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Oral Proteins and Peptides Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Oral Proteins and Peptides Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Linaclotide
  • Insulin
  • Plecanatide
  • Cyclosporine
  • Octreotide
Applications
  • Gastric & Digestive Disorders
  • Bone Diseases
  • Diabetes
  • Hormonal Disorders
Companies covered
  • Ironwood & Allergan
  • Novo Nordisk
  • Synergy Pharmaceuticals （Salix）
  • Novartis
  • Chiasma (Amryt Pharma)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oral Proteins and Peptides Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Oral Proteins and Peptides Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Oral Proteins and Peptides Market by Type
  6. 1.3.1 Linaclotide
  7. 1.3.2 Insulin
  8. 1.3.3 Plecanatide
  9. 1.3.4 Cyclosporine
  10. 1.3.5 Octreotide
  11. 1.4 Global Oral Proteins and Peptides Market Size by Type
  12. 1.4.1 Global Oral Proteins and Peptides Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Oral Proteins and Peptides Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Oral Proteins and Peptides Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Oral Proteins and Peptides Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Oral Proteins and Peptides Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Oral Proteins and Peptides Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Oral Proteins and Peptides Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Oral Proteins and Peptides Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Oral Proteins and Peptides Industry Trends
  2. 2.2 Oral Proteins and Peptides Industry Drivers
  3. 2.3 Oral Proteins and Peptides Industry Opportunities and Challenges
  4. 2.4 Oral Proteins and Peptides Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Oral Proteins and Peptides Revenue (2021-2026)
  2. 3.2 Global Top Players by Oral Proteins and Peptides Sales (2021-2026)
  3. 3.3 Global Top Players by Oral Proteins and Peptides Price (2021-2026)
  4. 3.4 Global Oral Proteins and Peptides Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oral Proteins and Peptides Major Company Production Sites & Headquarters
  6. 3.6 Global Oral Proteins and Peptides Company, Product Type & Application
  7. 3.7 Global Oral Proteins and Peptides Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oral Proteins and Peptides Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oral Proteins and Peptides Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oral Proteins and Peptides Tier 1, Tier 2, and Tier 3
4 Oral Proteins and Peptides Regional Status and Outlook
  1. 4.1 Global Oral Proteins and Peptides Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Oral Proteins and Peptides Historic Market Size by Region
  3. 4.2.1 Global Oral Proteins and Peptides Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Oral Proteins and Peptides Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Oral Proteins and Peptides Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Oral Proteins and Peptides Forecasted Market Size by Region
  7. 4.3.1 Global Oral Proteins and Peptides Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Oral Proteins and Peptides Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Oral Proteins and Peptides Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oral Proteins and Peptides by Application
  1. 5.1 Oral Proteins and Peptides Market by Application
  2. 5.1.1 Gastric & Digestive Disorders
  3. 5.1.2 Bone Diseases
  4. 5.1.3 Diabetes
  5. 5.1.4 Hormonal Disorders
  6. 5.2 Global Oral Proteins and Peptides Market Size by Application
  7. 5.2.1 Global Oral Proteins and Peptides Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Oral Proteins and Peptides Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Oral Proteins and Peptides Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Oral Proteins and Peptides Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Oral Proteins and Peptides Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Oral Proteins and Peptides Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Oral Proteins and Peptides Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Oral Proteins and Peptides Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Ironwood & Allergan
  2. 6.1.1 Ironwood & Allergan Company Information
  3. 6.1.2 Ironwood & Allergan Business Overview
  4. 6.1.3 Ironwood & Allergan Oral Proteins and Peptides Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Ironwood & Allergan Oral Proteins and Peptides Product Portfolio
  6. 6.1.5 Ironwood & Allergan Recent Developments
  7. 6.2 Novo Nordisk
  8. 6.2.1 Novo Nordisk Company Information
  9. 6.2.2 Novo Nordisk Business Overview
  10. 6.2.3 Novo Nordisk Oral Proteins and Peptides Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novo Nordisk Oral Proteins and Peptides Product Portfolio
  12. 6.2.5 Novo Nordisk Recent Developments
  13. 6.3 Synergy Pharmaceuticals （Salix）
  14. 6.3.1 Synergy Pharmaceuticals （Salix） Company Information
  15. 6.3.2 Synergy Pharmaceuticals （Salix） Business Overview
  16. 6.3.3 Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Product Portfolio
  18. 6.3.5 Synergy Pharmaceuticals （Salix） Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Oral Proteins and Peptides Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Oral Proteins and Peptides Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Chiasma (Amryt Pharma)
  26. 6.5.1 Chiasma (Amryt Pharma) Company Information
  27. 6.5.2 Chiasma (Amryt Pharma) Business Overview
  28. 6.5.3 Chiasma (Amryt Pharma) Oral Proteins and Peptides Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Chiasma (Amryt Pharma) Oral Proteins and Peptides Product Portfolio
  30. 6.5.5 Chiasma (Amryt Pharma) Recent Developments
7 North America by Country
  1. 7.1 North America Oral Proteins and Peptides Sales by Country
  2. 7.1.1 North America Oral Proteins and Peptides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Oral Proteins and Peptides Sales by Country (2021-2026)
  4. 7.1.3 North America Oral Proteins and Peptides Sales Forecast by Country (2027-2032)
  5. 7.2 North America Oral Proteins and Peptides Market Size by Country
  6. 7.2.1 North America Oral Proteins and Peptides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Oral Proteins and Peptides Market Size by Country (2021-2026)
  8. 7.2.3 North America Oral Proteins and Peptides Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Oral Proteins and Peptides Sales by Country
  2. 8.1.1 Europe Oral Proteins and Peptides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Oral Proteins and Peptides Sales by Country (2021-2026)
  4. 8.1.3 Europe Oral Proteins and Peptides Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Oral Proteins and Peptides Market Size by Country
  6. 8.2.1 Europe Oral Proteins and Peptides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Oral Proteins and Peptides Market Size by Country (2021-2026)
  8. 8.2.3 Europe Oral Proteins and Peptides Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Oral Proteins and Peptides Sales by Country
  2. 9.1.1 Asia-Pacific Oral Proteins and Peptides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Oral Proteins and Peptides Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Oral Proteins and Peptides Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Oral Proteins and Peptides Market Size by Country
  6. 9.2.1 Asia-Pacific Oral Proteins and Peptides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Oral Proteins and Peptides Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Oral Proteins and Peptides Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Oral Proteins and Peptides Sales by Country
  2. 10.1.1 South America Oral Proteins and Peptides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Oral Proteins and Peptides Sales by Country (2021-2026)
  4. 10.1.3 South America Oral Proteins and Peptides Sales Forecast by Country (2027-2032)
  5. 10.2 South America Oral Proteins and Peptides Market Size by Country
  6. 10.2.1 South America Oral Proteins and Peptides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Oral Proteins and Peptides Market Size by Country (2021-2026)
  8. 10.2.3 South America Oral Proteins and Peptides Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Oral Proteins and Peptides Sales by Country
  2. 11.1.1 Middle East and Africa Oral Proteins and Peptides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Oral Proteins and Peptides Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Oral Proteins and Peptides Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Oral Proteins and Peptides Market Size by Country
  6. 11.2.1 Middle East and Africa Oral Proteins and Peptides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Oral Proteins and Peptides Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Oral Proteins and Peptides Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Oral Proteins and Peptides Value Chain Analysis
  2. 12.1.1 Oral Proteins and Peptides Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Oral Proteins and Peptides Production Mode & Process
  7. 12.2 Oral Proteins and Peptides Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Oral Proteins and Peptides Distributors
  10. 12.2.3 Oral Proteins and Peptides Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst